Abstract
Malaria is a protozoan parasitic infection threatening millions of people throughout the world. Over 6 million cases of malaria are treated annually and in Africa alone one million infant deaths can be attributed directly to malaria. Chloroquine has been the mainstay of malaria chemotherapy for nearly 50 years, but widespread resistance now limits its usefulness. Stephen Ward outlines the pharmacology of this drug. possible mechanisms of parasite resistance and pharmacologically based strategies that may be useful in attempting to override this resistance.
| Original language | English |
|---|---|
| Pages (from-to) | 241-246 |
| Number of pages | 6 |
| Journal | Trends in Pharmacological Sciences |
| Volume | 9 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1 Jul 1988 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Mechanisms of chloroquine resistance in malarial chemotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver